コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 e rate is further accelerated on addition of heat shock protein 90.
2 ctor receptor, cyclin-dependent kinases, and heat shock protein 90.
3 nd absence of functional molecular chaperone heat shock protein 90.
4 he impact of phosphosites in the L. donovani heat shock protein 90.
5 mplex that includes at least HYL1, AGO1, and HEAT SHOCK PROTEIN 90.
6 y to gamma-enolase (8%); alpha-enolase (9%); heat-shock protein 90 (13%); osteopontin (4%); ubiquitin
7 /Zn-superoxide dismutase (SOD) but increased heat shock protein-90, a chaperone that facilitates prot
10 orms part of a protein complex that includes heat shock protein 90-alpha (HSP90-alpha), a molecular c
11 geldanamycin, an inhibitor of the chaperone heat shock protein 90, also increased both wild-type and
12 tigation revealed that SHP-2 interacted with heat shock protein 90, an important chaperone protein pr
13 ase 5 (PP5) has been found in complexes with heat shock protein 90 and glucocorticoid receptors and m
14 sing specific inhibitors revealed a role for heat shock protein 90 and glycogen synthase kinase 3 but
15 Emodin decreased the association of AR and heat shock protein 90 and increased the association of A
16 R-499 cardiomyopathy phenotype, including of heat shock protein 90 and protein serine/threonine phosp
17 90, which disrupted the interaction between heat shock protein 90 and TAp73 and thus promoted the pr
18 y, this conformational change was opposed by heat-shock protein 90 and did not require the MDM2 RING-
19 s a conformational change that is opposed by heat-shock protein 90 and precedes p53 ubiquitination.
20 The ATPase-driven dimeric molecular Hsp90 (heat shock protein 90) and its cofactor Cdc37 (cell divi
21 n combination with cytotoxics, inhibitors of heat shock protein 90, and inhibitors of proteasome func
23 kinase A, epidermal growth factor receptor, heat shock protein 90, and platelet-derived growth facto
27 face expression of heat shock protein 60 and heat shock protein 90, as well as improve DC function, w
28 s known to inhibit the chaperone function of heat shock protein 90, as well as induce growth arrest a
29 perone complex with mutant GCase and reduced heat-shock protein 90-associated protein degradation.
30 rough a proteomics screen, we identified the heat shock protein 90 B (hsp90B) chaperone as a direct M
33 ly revealed that the intracellular chaperone heat-shock protein 90 beta (HSP90beta) is present extrac
34 nts specifically reacted with the sumoylated heat-shock protein 90 beta isoform-alpha (HSP90-SUMO1, w
36 ial heat shock protein 90, but not cytosolic heat shock protein 90, binds and stabilizes the electron
37 33) pool formation required active cytosolic heat-shock protein 90 but not ER g96 and uniquely enable
40 shock protein 40, heat shock protein 70, and heat shock protein 90 by enzyme-linked immunosorbent ass
41 gulation of TAp73 protein stability by HDAC1-heat shock protein 90 chaperone complex, and our data su
42 ted by 17-beta-estradiol and interact within heat shock protein 90 chaperone complexes, together with
43 o reconstitution system whereby the cellular heat shock protein 90 chaperone system activates recombi
45 ng and that SNCG can replace the function of heat shock protein 90, chaperone ER-alpha36 activity, st
46 tudies suggest that EphA2 represents a novel heat shock protein 90 client protein and that the treatm
47 directly interacts with PIH1D1, a subunit of heat-shock protein 90 cochaperone R2TP complex, which is
54 thioredoxin 1), increased the expression of heat shock protein 90, heat shock protein 70, Bcl-2, Bcl
55 f RanBP9 to physically interact with tau and heat shock protein 90/heat shock cognate 70 (Hsp90/Hsc70
56 ed that small-molecule inhibitors, including heat-shock protein 90, histone deacetylase, PI3K/AKT, an
58 acts by modulating the chaperone activity of heat shock protein 90 (Hsp90) and blocking the binding o
59 was dependent on the chaperoning function of heat shock protein 90 (HSP90) and co-accompanied by the
63 otein via augmenting the interaction between heat shock protein 90 (Hsp90) and HIF-1alpha protein.
64 5C) is known to interact with the chaperonin heat shock protein 90 (HSP90) and is involved in the reg
65 (EC144), is a second generation inhibitor of heat shock protein 90 (Hsp90) and is substantially more
67 on to the nucleus to identify a link between heat shock protein 90 (HSP90) and protein kinase A (PKA)
68 lysosomal membrane, where it interacts with heat shock protein 90 (HSP90) and stabilizes binding of
69 s from inhibition of the molecular chaperone heat shock protein 90 (HSP90) and subsequent degradation
71 with molecular targeted agents that inhibit heat shock protein 90 (Hsp90) and/or mammalian target of
72 tibodies targeting citrullinated isoforms of heat shock protein 90 (HSP90) are associated with rheuma
74 ach identified geldanamycin, an inhibitor of heat shock protein 90 (HSP90) as a candidate therapeutic
79 sGC (sGCbeta) is critical for function, and heat shock protein 90 (HSP90) associates with heme-free
82 ves correlated with increased binding to the heat shock protein 90 (HSP90) chaperone and with higher
85 We have investigated mechanisms involved in heat shock protein 90 (Hsp90) chaperone-mediated cross p
87 tein kinases are the most prominent group of heat shock protein 90 (Hsp90) clients and are recruited
88 s, previously isolated from ICC samples, are heat shock protein 90 (HSP90) clients and undergo rapid
89 of CK2 and EGFR also caused deactivation of heat shock protein 90 (Hsp90) co-chaperone Cdc37, which
92 l division cycle 37 homolog (Cdc37) is a key heat shock protein 90 (Hsp90) cochaperone for protein ki
99 ecular chaperones, especially members of the heat shock protein 90 (Hsp90) family, are thought to pro
100 Akt phosphorylation via the dissociation of heat shock protein 90 (Hsp90) from its client protein 3-
101 of cells with geldanamycin, an inhibitor of heat shock protein 90 (Hsp90) function, also resulted in
102 ave demonstrated here that the inhibition of heat shock protein 90 (Hsp90) functions by small interfe
103 to determine whether the molecular chaperone heat shock protein 90 (HSP90) has an effect on both reco
105 Leveraging the unique surface expression of heat shock protein 90 (Hsp90) in breast cancer provides
108 Nitration of the pro-survival chaperone heat shock protein 90 (Hsp90) in position 33 and 56 indu
111 rticipate in communicating with LGG and that heat shock protein 90 (HSP90) in these vesicles might me
112 estigated the role of the cellular chaperone heat shock protein 90 (Hsp90) in viral RNA replication c
113 Here we show that LRRK2 forms a complex with heat shock protein 90 (Hsp90) in vivo and that inhibitio
120 FDG PET for imaging of tumor response to the heat shock protein 90 (Hsp90) inhibitor 17-allylamino-17
121 Chk1 is depleted when cells are treated with heat shock protein 90 (Hsp90) inhibitor 17-allylamino-17
125 n novologue (a novobiocin-based, C-terminal, heat shock protein 90 (Hsp90) inhibitor) that decreases
126 to kinase inhibition, an orally administered heat shock protein 90 (Hsp90) inhibitor, IPI-504, was ev
128 The discovery and clinical development of heat shock protein 90 (Hsp90) inhibitors continue to pro
131 hat the combination of glutaminase (GLS) and heat shock protein 90 (Hsp90) inhibitors selectively tri
133 srupting client-chaperone interactions using heat shock protein 90 (Hsp90) inhibitors would result in
162 g tumorigenesis, the chaperoning activity of heat shock protein 90 (HSP90) is often exploited by canc
168 s mediated by bortezomib-induced exposure of heat shock protein 90 (hsp90) on the surface of dying ce
179 ures of cyclin dependent kinase 2 (CDK2) and heat shock protein 90 (HSP90) to assess the performance
182 (SF3B2 and ataxin-2) of a chaperone protein, heat shock protein 90 (Hsp90) when co-administered with
183 7-AAG) inhibits the chaperone association of heat shock protein 90 (hsp90) with the heat shock factor
185 Na(+) and/or K(+) flux and the activation of heat shock protein 90 (HSP90), a protein required for th
186 lls: telomerase-associated protein 1 (TEP1), heat shock protein 90 (HSP90), and topoisomerase IIalpha
187 ane potential, did not require the chaperone Heat Shock Protein 90 (Hsp90), and was inhibited by cyto
188 In search for an HDAC6 target, we found that heat shock protein 90 (Hsp90), another prominent substra
190 that could regulate the GR chaperone protein heat shock protein 90 (HSP90), in the synaptic action of
191 function of the dimeric molecular chaperone heat shock protein 90 (Hsp90), including transient, ATP-
192 uces acetylation of histone H3 and H4 and of heat shock protein 90 (hsp90), increases p21 levels, as
193 tics, such as geldanamycin, potently inhibit heat shock protein 90 (Hsp90), promoting ubiquitin-media
194 ted protein 94 (Grp94), the ER equivalent of heat shock protein 90 (Hsp90), specifically recognizes m
195 nt phenethyl isothiocyanate (PEITC) inhibits heat shock protein 90 (Hsp90), the main negative regulat
197 82 colocalized and coimmunoprecipitated with heat shock protein 90 (HSP90), which increased upon alco
198 that RIP1 formed a complex with Triad3A and heat shock protein 90 (Hsp90), which is a chaperone prot
199 is required for the association of Ago2 with heat shock protein 90 (Hsp90), which is necessary for th
202 ivity of these inhibitors was tested against heat shock protein 90 (HSP90), which possesses a similar
203 ity of JAK2-dependent cells to inhibitors of heat shock protein 90 (HSP90), which promote the degrada
205 C-1-interacting proteins that are well-known heat shock protein 90 (Hsp90)-associated co-chaperones:
206 er promoted T lymphocyte trafficking through heat shock protein 90 (Hsp90)-induced alpha4 integrin ac
225 e, we have shown that selective targeting of heat shock protein-90 (Hsp90) chaperones in mitochondria
229 ugh interference of cyclophilin-D binding to heat shock protein-90 (Hsp90) in mitochondria, rendering
231 al proteins, such as the molecular chaperone heat shock protein-90 (Hsp90), in promoting cancer cell
234 othelium, potentially due to dissociation of heat shock proteins 90 (Hsp90), and cellular glucose hom
239 p-regulation of the folding machinery of the heat-shock protein 90 (Hsp90) chaperone protein is cruci
241 Here we investigated the role of cellular heat-shock protein 90 (HSP90) in AAV transduction becaus
243 o address this need, we explored the role of heat-shock protein 90 (Hsp90) in opioid-induced MOR sign
248 In this study we examined the effect of heat-shock protein 90 (HSP90) inhibitor, geldanamycin (G
249 ylamino]-17-demethoxygeldanamycin (17AAG), a heat-shock protein 90 (Hsp90) inhibitor, prevents UVR-in
257 aperone UNC45B, in addition to the chaperone heat-shock protein 90 (HSP90) significantly increased th
258 Galpha12 mutants showed impaired binding to heat-shock protein 90 (Hsp90) while retaining binding to
259 d that ZAP-70+ CLL cells expressed activated heat-shock protein 90 (Hsp90) with high binding affinity
260 homeostasis, molecular chaperones, including heat-shock protein 90 (Hsp90), represent attractive drug
264 rol interfered with the establishment of the heat-shock protein 90/Hsp90 cochaperone Cdc37/Hsp90-Hsp7
266 e the role of the molecular chaperone hsp90 (heat shock protein 90) in excitatory synaptic transmissi
267 le, in response to replicative stress and on heat shock protein 90 inhibition, and that deregulation
268 HER2 protein on treatment of tumor mice with heat shock protein 90 inhibitor 17-N,N-dimethyl ethylene
269 ne, the JAK1/2 inhibitor ruxolitinib, or the heat shock protein 90 inhibitor 8-(6-iodobenzo[d][1.3]di
270 f EphA2(+) tumor cells with the irreversible heat shock protein 90 inhibitor, 17-dimethylaminoethylam
275 that the interactions of AID with eEF1A and heat-shock protein 90 kD (HSP90) are inversely correlate
276 is the endoplasmic reticulum resident of the heat shock protein 90 kDa (Hsp90) family of molecular ch
279 doses (40 mg/kg) of 17-DMAG, an inhibitor of heat-shock protein 90, known to decrease HER2 expression
281 ck protein 70 were increased while placental heat shock protein 90 levels were decreased in hypoxic p
284 gly, alvespimycin, a potent inhibitor of the heat-shock protein 90 molecular chaperone, markedly inhi
286 lity group box 1, heat shock protein 70, and heat shock protein 90; negatively regulates their stimul
287 aused NO-dependent dissociation of HSF1 from heat shock protein 90, nuclear translocation of HSF1, an
288 d by the endoplasmic reticulum (ER)-resident heat shock protein 90 paralog, glucose regulated protein
290 these inhibitors limit the deacetylation of heat shock protein 90, resulting in less recognition of
293 itro; and enhanced the binding of acetylated heat shock protein 90 to lymphocyte-specific protein tyr
294 dehydrogenase, alpha-enolase, filamin-A, and heat shock protein 90, were identified in samples of api
295 (required for Mla12 resistance), and Hsp90 (heat shock protein 90), which are known to participate e
296 ng cascade was mediated downstream by Hsp90 (heat shock protein 90), which in turn modulated mitochon
297 lted in hyperacetylation and inactivation of heat shock protein 90, which disrupted the interaction b
298 inase induces its complexing with 14-3-3 and heat shock protein 90, which is facilitated by the longe
300 and autolytimycin (2) were shown to bind the heat shock protein 90 with enhanced binding activity (ap